Lri Investments, LLC Rigel Pharmaceuticals Inc Transaction History
Lri Investments, LLC
- $1.22 Trillion
- Q3 2025
A detailed history of Lri Investments, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Lri Investments, LLC holds 124 shares of RIGL stock, worth $4,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124Holding current value
$4,003% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RIGL
# of Institutions
8Shares Held
334KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY323KShares$10.4 Million0.76% of portfolio
-
Bergan Kdv Wealth Management, LLC10KShares$322,9000.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA730Shares$23,5710.0% of portfolio
-
Versant Capital Management, Inc224Shares$7,2320.0% of portfolio
-
Institutional & Family Asset Management, LLC10Shares$3220.0% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $5.58B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...